光正眼科
(002524)
| 流通市值：21.78亿 | | | 总市值：22.14亿 |
| 流通股本：5.10亿 | | | 总股本：5.18亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 436,153,289.26 | 208,167,536.89 | 892,842,271.65 | 698,778,682.45 |
| 营业收入 | 436,153,289.26 | 208,167,536.89 | 892,842,271.65 | 698,778,682.45 |
| 二、营业总成本 | 438,708,944.32 | 210,803,000.59 | 937,439,817.91 | 722,117,114.93 |
| 营业成本 | 272,063,851.98 | 129,879,287.6 | 563,895,680.2 | 440,914,261.56 |
| 税金及附加 | 2,317,461.89 | 1,364,467.6 | 4,275,266.56 | 3,433,389.64 |
| 销售费用 | 86,358,122.66 | 40,476,044.87 | 187,697,083.27 | 143,713,024.94 |
| 管理费用 | 58,448,364.38 | 29,204,583.3 | 138,838,602.42 | 103,513,659.62 |
| 研发费用 | 1,250,004 | 625,006 | 3,580,360.61 | 1,877,901.94 |
| 财务费用 | 18,271,139.41 | 9,253,611.22 | 39,152,824.85 | 28,664,877.23 |
| 其中:利息费用 | 17,881,928.34 | 8,982,567.81 | 38,379,206.64 | 28,335,160.19 |
| 其中:利息收入 | 324,586.36 | 107,217.96 | 636,631.11 | 938,026.45 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 4,682,389.73 | 2,587,132.19 | 14,768,363.72 | 8,303,343.84 |
| 资产处置收益 | 342,994.13 | 1,397.07 | 5,020,865.74 | 4,944,019.66 |
| 资产减值损失(新) | -16,266.59 | 374,869.55 | -133,155,370.85 | -253,136.45 |
| 信用减值损失(新) | 1,494,082.95 | 1,201,040.93 | -3,408,297.1 | -1,487,525.86 |
| 其他收益 | 683,075.35 | 286,291.34 | 4,890,451.74 | 1,044,660.73 |
| 四、营业利润 | 4,630,620.51 | 1,815,267.38 | -156,481,533.01 | -10,787,070.56 |
| 加:营业外收入 | 1,207,873.84 | 76,022.67 | 567,090.96 | 250,173.38 |
| 减:营业外支出 | 2,736,086.35 | 654,737.54 | 5,172,305.87 | 4,802,468.4 |
| 五、利润总额 | 3,102,408 | 1,236,552.51 | -161,086,747.92 | -15,339,365.58 |
| 减:所得税费用 | 2,091,829.84 | 495,171.23 | 13,890,014.65 | 4,945,101.06 |
| 六、净利润 | 1,010,578.16 | 741,381.28 | -174,976,762.57 | -20,284,466.64 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 1,010,578.16 | 741,381.28 | -174,976,762.57 | -20,284,466.64 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 1,418,926.14 | 573,756.72 | -174,653,435.06 | -20,808,633.35 |
| 少数股东损益 | -408,347.98 | 167,624.56 | -323,327.51 | 524,166.71 |
| 扣除非经常损益后的净利润 | -3,279,782.89 | -1,593,569.15 | -194,526,829.68 | -29,431,429.95 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | 0 | -0.34 | -0.04 |
| (二)稀释每股收益 | 0 | 0 | -0.34 | -0.04 |
| 八、其他综合收益 | - | - | 408,800 | - |
| 归属于母公司股东的其他综合收益 | - | - | 408,800 | - |
| 九、综合收益总额 | 1,010,578.16 | 741,381.28 | -174,567,962.57 | -20,284,466.64 |
| 归属于母公司股东的综合收益总额 | 1,418,926.14 | 573,756.72 | -174,244,635.06 | -20,808,633.35 |
| 归属于少数股东的综合收益总额 | -408,347.98 | 167,624.56 | -323,327.51 | 524,166.71 |
| 公告日期 | 2025-08-22 | 2025-04-28 | 2025-04-24 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |